Effectiveness of Volbella (VYC-15L) for Infraorbital Hollowing: Patient-Reported Outcomes From a Prospective, Multicenter, Single-Blind, Randomized, Controlled Study
Fabi S
Published in Aesthetic Surgery Journal
Methodology
Prospective, multicentre, single-blind randomized controlled study of VYC-15L injection for infraorbital hollowing with validated patient-reported outcome instruments assessed to 12 months.
Key Findings
Hyaluronic acid filler (VYC-15L) for infraorbital hollowing produced sustained patient-reported improvement in under-eye appearance and reduced bother from dark circles and tear-trough hollowing through 12 months versus untreated control.
Conclusions
Hyaluronic acid filler for infraorbital hollowing reduced bother from under-eye dark circles through 12 months.
Limitations
Single-blind design with no sham injection, patient-reported subjective endpoints, industry sponsorship, and results specific to filler rather than any topical or supplemental intervention.
Supplements Studied
Most VYC-15L-treated participants reported not feeling moderately or very bothered by dark circles under their eyes.
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Sponsored by Allergan Aesthetics / AbbVie, manufacturer of the study product.
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.